XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Operating Activities      
Net Loss $ (2,817,609) $ (1,223,519)  
Adjustments to reconcile net loss to net cash from operating activities:      
Shares, options and warrants issued for services 1,224,677 565,261  
Depreciation and amortization 111,039 7,843  
Interest on lease liability 12,302 915  
Accrued interest 7,874 17,010  
Amortization on OID interest 211,340  
Gain/(loss) on settlement of debt (9,207)  
 Adjustments to reconcile net income loss to cash provided by (used in) operating activities (1,461,717) (430,357)  
Changes in operating assets and liabilities (note 9) (554,762) (76,510)  
Net cash used in operating activities (2,016,479) (506,867)  
Cash Flows from Investing Activities      
Loan receivable (5,507)  
Purchase of property and equipment (614,046) (119,233)  
Net cash used in investing activities (614,046) (124,740)  
Financing Activities      
Repayment of lease liability (126,007) (7,515)  
Proceeds from issuance of common shares, net of issuance cost 5,993,441  
Proceeds from warrant exercise 2,932,105  
Shareholder Assumption of Debt (1,863) (19,453)  
Repayments on loan payable (62,905)  
Net cash provided by/ used in financing activities (127,870) 8,835,673  
Change in cash (2,758,395) 8,204,006  
Cash and cash equivalents - beginning of year 28,567,333 1,107,812 $ 1,107,812
Cash and cash equivalents end of year 25,808,938 9,311,878 $ 28,567,333
Supplemental Disclosure of non-cash investing and financing Activities      
Shares issued for purchase of software 141,781 69,315  
Shares and warrants issued to service providers 604,401 515,818  
Cashless warrant exercise 51,901  
Conversion of convertible promissory note to common stock $ 368,320